Tatjana Zaharov

Tatjana Zaharov

Auto-generated profile, based on publicly available information

Tatjana Zaharov

Department of Pediatrics Nykobing Falster Hospital Nykobing Falster Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2009 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
BBBojko Bjelakovic
Bojko Bjelakovic
SIStevan Ilic
Stevan Ilic
KCKonstantinos Chouliaras
Konstantinos Chouliaras
BMBranislav Milovanović
Branislav Milovanović
VVVladislav Vukomanovic
Vladislav Vukomanovic
TZTatjana Zaharov
Tatjana Zaharov

15 July 2024
Verified
Preprint
Open access
TZTatjana Zaharov
Tatjana Zaharov
KFKristina Træholt Franck
Kristina Træholt Franck
UNUlrikka Nygaard
Ulrikka Nygaard
KKKim Kristensen
Kim Kristensen
Background : Studies have shown a high risk of interstitial lung disease after hospitalization with adenovirus (AdV) and a high risk of asthma after hospitalization with respiratory syncytial virus (RSV) Objective : To clarify to what extent children hospitalized with respiratory tract infection caused by AdV or RSV develop pulmonary disease Design : Register-based cohort study Methods : Data on infections with AdV and RSV were coupled to data on asthma, asthma medication bronchiectasia, and interstitial lung disease including bronchiolitis obliterans during a follow-up time of 15 – 20 years. An age-matched control group was also generated. The risks of subsequent lung disease and/or having received asthma medication and hazard ratios (HRs) for asthma between the index groups and the control group were computed Findings : In total 4704 children were included. Less than 5 cases of interstitial lung disease or bronchiectasia were found in any group. After hospitalization with AdV or RSV the risk of acquiring an asthma diagnosis or having received asthma medication during follow up was 29% and 65%, respectively for AdV, and 22% and 51%, respectively for RSV; corresponding to adjusted HRs of 2.16 (0.92-5.07), 2.60 (1.57-4.31), 2.87 (2.30-3.58), and 2.37 (2.07-2.71), respectively Conclusion : We could not confirm an increased risk of interstitial lung disease after infection with AdV. However, there is a considerable risk of asthma after hospitalization with AdV or RSV and with respect to RSV the risk is higher than previously reported as expressed by the fraction having received asthma medication during follow up

25 September 2026 in Acta Paediatrica
Verified
Journal Article
Open access
SHSara Krøis Holm
Sara Krøis Holm
LALise Aunsholt
Lise Aunsholt
PPPorntiva Poorisirak
Porntiva Poorisirak
ANAlex Christian Yde Nielsen Nielsen
Alex Christian Yde Nielsen Nielsen
RPRune Micha Pedersen
Rune Micha Pedersen
SLStine Lund
Stine Lund
Aim: Postnatally acquired cytomegalovirus (pCMV) infection may cause severe disease in extremely preterm infants, but its clinical significance remains uncertain. We investigated the incidence, timing, disease burden, and diagnostic performance of saliva screening. Method: In this prospective cohort study, infants born at < 28 weeks of gestation or with a birth weight < 1200 g to CMV‐seropositive mothers and fed untreated mothers' own milk underwent weekly saliva and urine CMV polymerase chain reaction testing. Outcomes before discharge and at 2 years corrected age were compared between CMV‐positive and CMV‐negative infants. Results: Forty‐five infants were included, of whom 20 (44%) acquired pCMV. CMV was detected at a median age of 44 days in saliva, 50 days in urine, and 55 days in blood. Two (10%) infected infants developed severe disease requiring antiviral treatment. No significant differences were observed in neonatal morbidity, hospitalisation duration, mortality, or neurodevelopmental outcomes. Saliva PCR demonstrated a sensitivity of 86% and a specificity of 93%. Conclusion: pCMV transmission was common in extremely preterm infants receiving mothers' own milk, but clinically significant disease occurred in only a minority of infected infants. Saliva‐based screening demonstrated acceptable diagnostic performance and may facilitate early recognition and targeted management of clinically significant pCMV infection.